Revvity Inc. Insider Trading

RVTY

Last 12 months

Insiders sold $5.97M and bought nothing on the open market.

99% of the selling was scheduled in advance under 10b5-1 plans. Director Michelle McMurry-Heath sold 58K on Feb 23, 12% of their stake, outside a plan. The last open-market buy by an executive or director was in Nov 2012.

Net open-market

−$5.97M

0 buys · 10 sales

Under a 10b5-1 plan

99%

of the value sold

Insiders who bought / sold

0 / 7

executives and directors

Last open-market buy

Nov 2012

Nov 26, 2012

Get an email when RVTY's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Oct 1	Anita Gonzales VP and CAO	Sold10b5-1 plan	84	$155.48	13K	1.2%	Form 4
Sep 21	Maxwell Krakowiak Please See Remarks	Sold10b5-1 plan	1,631	$144.53	236K	9.9%	Form 4
Sep 16	Tajinder S Vohra Please See Remarks	Sold10b5-1 plan	7,330	$140.88	$1.03M	52%	Form 4
Jul 20	Anita Gonzales Vice President and CAO	Sold10b5-1 plan	85	$109.48	9K	1.2%	Form 4
Apr 20	Anita Gonzales Vice President and CAO	Sold10b5-1 plan	80	$92.80	7K	1.1%	Form 4
Feb 24	Miriame Victor Please See Remarks	Sold10b5-1 plan	1,862	$97.13	181K	9.3%	Form 4
Feb 23	Michelle McMurry-Heath Director	SoldNo plan	600	$97.26	58K	12%	Form 4
Feb 5	Prahlad R. Singh Please See Remarks	Sold10b5-1 plan 5 parts	25,525	$100.21 average	$2.56M	13%	Form 4
Feb 5	Joel S Goldberg Please See Remarks	Sold10b5-1 plan 4 parts	12,717	$100.21 average	$1.27M	11%	Form 4
Feb 2	Tajinder S Vohra Please See Remarks	Sold10b5-1 plan	5,756	$104.50	602K	36%	Form 4
Aug 27, 2025	Alexis P Michas Director	SoldNo plan	500	$89.01	45K	0.7%	Form 4
May 29, 2025	Michelle McMurry-Heath Director	SoldNo plan	600	$92.17	55K	11%	Form 4
Feb 6, 2025	Michelle McMurry-Heath Director	SoldNo plan	1,970	$119.49	235K	39%	Form 4
Jan 30, 2025	Joel S Goldberg Please See Remarks	Sold10b5-1 plan 4 parts	15,170	$126.73 average	$1.92M	14%	Form 4
Jan 7, 2025	Tajinder S Vohra Please See Remarks	Sold10b5-1 plan 4 parts	5,492	$116.81 average	642K	22%	Form 4
Dec 2, 2024	Prahlad R. Singh Please See Remarks	Sold10b5-1 plan 2 parts	18,365	$116.22 average	$2.13M	13%	Form 4

Oct 110b5-1 plan
Anita Gonzales
VP and CAO · sold 84 at $155.48
13K
1.2% of stake
Sep 2110b5-1 plan
Maxwell Krakowiak
Please See Remarks · sold 1,631 at $144.53
236K
9.9% of stake
Sep 1610b5-1 plan
Tajinder S Vohra
Please See Remarks · sold 7,330 at $140.88
$1.03M
52% of stake
Jul 2010b5-1 plan
Anita Gonzales
Vice President and CAO · sold 85 at $109.48
9K
1.2% of stake
Apr 2010b5-1 plan
Anita Gonzales
Vice President and CAO · sold 80 at $92.80
7K
1.1% of stake
Feb 2410b5-1 plan
Miriame Victor
Please See Remarks · sold 1,862 at $97.13
181K
9.3% of stake
Feb 23No plan
Michelle McMurry-Heath
Director · sold 600 at $97.26
58K
12% of stake
Feb 510b5-1 plan
Prahlad R. Singh
Please See Remarks · sold 25,525 at avg $100.21
$2.56M
13% of stake
Feb 510b5-1 plan
Joel S Goldberg
Please See Remarks · sold 12,717 at avg $100.21
$1.27M
11% of stake
Feb 210b5-1 plan
Tajinder S Vohra
Please See Remarks · sold 5,756 at $104.50
602K
36% of stake
Aug 27, 2025No plan
Alexis P Michas
Director · sold 500 at $89.01
45K
0.7% of stake
May 29, 2025No plan
Michelle McMurry-Heath
Director · sold 600 at $92.17
55K
11% of stake
Feb 6, 2025No plan
Michelle McMurry-Heath
Director · sold 1,970 at $119.49
235K
39% of stake
Jan 30, 202510b5-1 plan
Joel S Goldberg
Please See Remarks · sold 15,170 at avg $126.73
$1.92M
14% of stake
Jan 7, 202510b5-1 plan
Tajinder S Vohra
Please See Remarks · sold 5,492 at avg $116.81
642K
22% of stake
Dec 2, 202410b5-1 plan
Prahlad R. Singh
Please See Remarks · sold 18,365 at avg $116.22
$2.13M
13% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch RVTY, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Laboratory Analytical Instruments · Pick stocks to compare with RVTY

CompareIntrinsic value

BIOBio-Rad Laboratories Inc.

$379.99+1.35%48

BRKRBruker Corporation

$63.79+12.90%23

MTDMettler-Toledo International Inc.

$1,723.24+1.48%41

ILMNIllumina, Inc.

$226.54-4.90%68

WATWaters Corporation

$467.60+1.67%25

TXG10x Genomics Inc.

$67.52+3.42%48

AVTRAvantor Inc.

$15.65+0.38%22

AAgilent Technologies Inc.

$177.17+0.97%44

Held by ETFs

RVTY is in 170 US ETFs. The largest of them, with RVTY's weight in each:

Spot a number that looks wrong? Check it in RVTY's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing RVTY

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.